KPRXHealthcareNano-Cap
KIORA PHARMACEUTICALS INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for KIORA PHARMACEUTICALS INC (KPRX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are KPRX insiders buying or selling?
KIORA PHARMACEUTICALS INC insiders reported 21 open-market buys ($10.7M) and 9 sells ($15.3M) across 30 Form 4 filings — a net selling position of $4.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of Sep 12, 2024)
Total Form 4 filings
30
SEC EDGAR
Insider filers
15
Insider buys (21)
$10.7M
Insider sells (9)
$15.3M
Insider sentiment
Net sellingNet insider flow of $4.5M in net selling.
Recent KPRX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 12, 2024 | Carmine N. Stengone | Director | Purchase | 1.3K | $3.68 | $4.6K |
| Sep 11, 2024 | Aron Shapiro | Director | Purchase | 3.0K | $3.60 | $10.8K |
| Aug 20, 2024 | Walters-Hoffert Lisa | Director | Purchase | 1.3K | $3.86 | $4.8K |
| Aug 19, 2024 | Praveen Tyle | Director | Purchase | 5.0K | $3.96 | $19.8K |
| Aug 15, 2024 | Melissa Tosca | CFO | Purchase | 2.0K | $3.21 | $6.4K |
| Jun 14, 2024 | Melissa Tosca | EVP Finance | Purchase | 100 | $5.25 | $525 |
| Jun 14, 2024 | Eric Joseph Daniels | Chief Development Officer | Purchase | 1.4K | $5.29 | $7.6K |
| Jun 13, 2024 | Erin Parsons | Director | Purchase | 5.3K | $4.88 | $25.7K |
| Jun 13, 2024 | Brian M. Strem | President and CEO | Purchase | 3.0K | $5.00 | $15.0K |
| Nov 22, 2021 | Brian M. Strem | President and CEO | Purchase | 17.9K | $1.41 | $25.2K |
| Aug 3, 2021 | Steven Boyd | 10% Owner | Sale | 261.0K | $2.48 | $646.6K |
| Jul 29, 2021 | Steven Boyd | Director, 10% Owner | Sale | 3.2M | $4.61 | $14.5M |
| Jan 9, 2021 | Steven Boyd | Director, 10% Owner | Purchase | 1.5M | $5.23 | $8.0M |
| Feb 10, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 23.0K | $6.11 | $140.5K |
| Dec 6, 2019 | Morton Goldberg | Director | Sale | 2.0K | $6.93 | $13.6K |
| Nov 13, 2019 | Morton Goldberg | Director | Sale | 2.0K | $4.29 | $8.6K |
| Oct 1, 2019 | Steven Boyd | Director, 10% Owner | Purchase | 605.0K | $3.13 | $1.9M |
| Jul 16, 2019 | Sarah Romano | Chief Financial Officer | Sale | 19.8K | $0.24 | $4.7K |
| Jul 16, 2019 | MANZO MICHAEL P. | VP of Engineering | Sale | 19.8K | $0.24 | $4.7K |
| Jul 16, 2019 | Barbara Wirostko | Chief Medical Officer | Sale | 19.5K | $0.24 | $4.6K |
| Jul 16, 2019 | Stephen From | President and CEO | Sale | 127.4K | $0.24 | $30.1K |
| Jul 16, 2019 | Brenda Mann | VP of Research & Development | Sale | 19.0K | $0.24 | $4.5K |
| Mar 29, 2019 | Steven Boyd | Director, 10% Owner | Purchase | 549.6K | $0.32 | $175.2K |
| Dec 12, 2018 | Steven Boyd | Director, 10% Owner | Purchase | 100.4K | $0.40 | $40.3K |
| Nov 17, 2018 | Steven Boyd | Director, 10% Owner | Purchase | 360.0K | $0.45 | $161.4K |
Showing the 25 most recent of 30 Form 4 filings for KIORA PHARMACEUTICALS INC.
Most active KPRX insiders
- Steven Boyd13 filings
- Brian M. Strem2 filings
- Melissa Tosca2 filings
- Morton Goldberg2 filings
- Aron Shapiro1 filing
Ask anything about KPRX insider activity
Use Trabud's AI agent to query KIORA PHARMACEUTICALS INC's Form 4 history in plain English — "Show me KPRX CEO purchases this year" or compare it against any other ticker.
Open the AI agentKPRX insider trading FAQ
Are KIORA PHARMACEUTICALS INC insiders buying or selling?
Across 30 SEC Form 4 filings, KIORA PHARMACEUTICALS INC (KPRX) insiders reported 21 open-market purchases totaling $10.7M and 9 sales totaling $15.3M. That is a net selling position of $4.5M.
How many insiders trade KPRX stock?
15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for KIORA PHARMACEUTICALS INC. The most recent filing was accepted on Sep 12, 2024.
Where does Trabud get KPRX insider trading data?
All KPRX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.